ConductScience.org, home

Gene · 1129

Drugs31

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
AFACIFENACINCHEMBL3545165Muscarinic acetylcholine receptor antagonistANTAGONISTChEMBL
ALCURONIUMCHEMBL3305985Muscarinic acetylcholine receptor M2 positive allosteric modulatorPOSITIVE ALLOSTERIC MODULATORChEMBL
ASM-024CHEMBL3707249Muscarinic acetylcholine receptor M2 antagonistANTAGONISTChEMBL
ATROPINECHEMBL517712Muscarinic acetylcholine receptor M2 antagonistANTAGONISTChEMBL
ATROPINE SULFATECHEMBL2146146Muscarinic acetylcholine receptor M2 antagonistANTAGONISTChEMBL
BATEFENTEROLCHEMBL3039518Muscarinic acetylcholine receptor M2 antagonistANTAGONISTChEMBL
BETHANECHOLCHEMBL1482Muscarinic acetylcholine receptor M2 agonistAGONISTChEMBL
BETHANECHOL CHLORIDECHEMBL1768Muscarinic acetylcholine receptor M2 agonistAGONISTChEMBL
DARIFENACINCHEMBL1346Muscarinic acetylcholine receptor M2 antagonistANTAGONISTChEMBL
DARIFENACIN HYDROBROMIDECHEMBL1200935Muscarinic acetylcholine receptor M2 antagonistANTAGONISTChEMBL
DAROTROPIUMCHEMBL2365940Muscarinic acetylcholine receptor antagonistANTAGONISTChEMBL
DAROTROPIUM BROMIDECHEMBL2308782Muscarinic acetylcholine receptor antagonistANTAGONISTChEMBL
FESOTERODINECHEMBL1201764Muscarinic acetylcholine receptor M2 antagonistANTAGONISTChEMBL
FESOTERODINE FUMARATECHEMBL1201765Muscarinic acetylcholine receptor M2 antagonistANTAGONISTChEMBL
GLYCOPYRRONIUMCHEMBL1201335Muscarinic acetylcholine receptor inhibitorINHIBITORChEMBL
GLYCOPYRRONIUM TOSYLATECHEMBL3707243Muscarinic acetylcholine receptor inhibitorINHIBITORChEMBL
OXYBUTYNINCHEMBL1231Muscarinic acetylcholine receptor M2 antagonistANTAGONISTChEMBL
OXYBUTYNIN CHLORIDECHEMBL1133Muscarinic acetylcholine receptor M2 antagonistANTAGONISTChEMBL
PROPANTHELINECHEMBL1180725Muscarinic acetylcholine receptor M2 antagonistANTAGONISTChEMBL
PROPANTHELINE BROMIDECHEMBL1240Muscarinic acetylcholine receptor M2 antagonistANTAGONISTChEMBL

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/1129/drugs